Young Eye Researchers Receive Prestigious ARVO-AFER/Merck Award
Main Category: Eye Health / BlindnessAlso Included In: Diabetes; Biology / Biochemistry; Conferences
Article Date: 04 Apr 2009 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Four researchers under age 45 have been named as recipients of the 2009 ARVO-AFER/Merck Innovative Ophthalmology Research Award (IORA) for their work in glaucoma and back-of-the-eye diseases. The awards are worth a total of $70,000 for the researchers and their laboratories.
The IORA - made possible by a generous grant from Merck & Co. to the ARVO Foundation for Eye Research - recognizes outstanding young researchers under 45 every other year. The award encourages scientists to undertake investigative work in critical areas of ophthalmology that could lead to meaningful improvements to patients' lives.
First- and second-place awards are presented for each of the two categories. This cycle's recipients are:
First Place
Glaucoma
Mike Karl, MD ( University of Washington )
Submission: Stimulation of Neural Regeneration in the Mouse Retina
Back-of-the-eye diseases
Chung-Jung Chiu, PhD ( Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University )
Submission: Diet, Supplement and Risk of Age-related Macular Degeneration in the Age-Related Eye Disease Study
Second Place
Glaucoma
Wolf Lagreze, MD ( University Eye Hospital, Freiburg, Germany )
Retrobulbar Optic Nerve Diameter Measured By High Speed Magnetic Resonance
Imaging as a Biomarker for Axonal Loss in Glaucomatous Optic Atrophy
Back-of-the-eye diseases
Hyun Woong Kim, MD, PhD (Injje University College of Medicine, South Korea)
Submission: Effect of Enalapril on the Expression of Angiogenic Factors in Diabetes-induced
Retinopathy in Rats
Mike Karl, the glaucoma first place recipient, said: "It's great to receive this honor as a postdoctoral student, and a great reason to thank and celebrate with the lab, colleagues, friends, and past and current mentors."
"If there is any reason other than luck for my win, one of the most important reasons must be because I have many great mentors," commented Chung-Jung Chiu, who received the first-place aware in the Back of the Eye Diseases category.
The IORA was originally Merck's Chibret Award, created in 1982 to honor French ophthalmologist Dr. Paul Chibret. More than 50 scientists have since received the award.
The ARVO Foundation for Eye Research will recognize the 2009 IORA recipients in conjunction with the ARVO 2009 Annual Meeting, which takes place in Fort Lauderdale, FL, May 3-7.
Topics for the 2011 IORA will be announced later this year, and submissions will open in January 2010. See www.arvofoundation.org for more information.
Notes:
The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include some 12,500 eye and vision researchers from over 73 countries. The Association encourages and assists research, training, publication and dissemination of knowledge in vision and ophthalmology.
The ARVO Foundation for Eye Research complements ARVO's mission to cure and prevent blindness and eye disease by providing funds for innovative and novel vision research. The Foundation also supports training for eye researchers around the world; leads initiatives that encourage new vision scientists from emerging countries; and fosters global research collaboration.
Source:
Jessie Williams
Association for Research in Vision and Ophthalmology
Visit our eye health / blindness section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/145046.php>
APA
http://www.medicalnewstoday.com/releases/145046.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




